Sesen Bio is headquartered in Cambridge, Massachusetts.
Sesen Bio disclosed revenue of 40M USD for 2022 and 27M USD for 2021.
Sesen Bio has 27 employees.
Sesen Bio is a life science company.
Sesen Bio was founded in 2008.
245 First Street, Suite 1800,
Cambridge, Massachusetts
02142
United States,
(617) 444-8550
www.sesenbio.com
Sesen is a biologics oncology company focused on the development of novel therapies based upon tumor targeting antibody fragments genetically fused to a cytotoxic protein payload called Targeted Protein Therapeutics (TPTs). Eleven Sesen Bio was founded in 2008 and is based in Cambridge, Massachusetts.
| Year | ≤ '11 | '12 | '13 | '14 | '15 | '16 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.2/yr) | # | - | - | - | - | - | 1 | 1 |
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 1 | ||||||||
| Financial | Deals |
|---|---|
|
Stifel |
1 |
| Legal | Deals |
|---|---|
|
Wilmer Cutler Pickering Hale and Dorr |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
